Amanote Research
Register
Sign In
Accuracy, Safety, and Reliability of Novel Phase I Designs—Response
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-18-2677
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 1, 2018
Authors
Heng Zhou
Ying Yuan
Lei Nie
Publisher
American Association for Cancer Research (AACR)
Related search
Designs for Phase I Trials in Ordered Groups
Statistics in Medicine
Epidemiology
Statistics
Probability
Practical Designs for Phase I Combination Studies in Oncology
Journal of Biopharmaceutical Statistics
Statistics
Probability
Pharmacology
Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-In-Human Phase I Study”
Clinical Drug Investigation
Medicine
Pharmacology
I-Optimal Versus D-Optimal Split-Plot Response Surface Designs
Journal of Quality Technology
Industrial
Risk
Manufacturing Engineering
Strategy
Management Science
Reliability
Safety
Management
Quality
Operations Research
Sequential Designs for Phase I Clinical Trials With Late-Onset Toxicities
Biometrics
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Immunology
Biological Sciences
Medicine
Agricultural
Safety, Tolerability, and Pharmacokinetics of the Novel Anti-Influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
Clinical Drug Investigation
Medicine
Pharmacology
Reliability and Accuracy of Observational Gait Analysis
Rigakuryoho Kagaku
Physical Therapy
Sports Therapy
Rehabilitation
Randomized Phase II Designs
Clinical Cancer Research
Cancer Research
Oncology
Reliability Studies of Integrated Modular Engine System Designs
